Morrison & Foerster’s global co-head of M&A and London head of corporate has left the firm.

Graeme Sloan exited in March, he confirmed, to join a life sciences client that is currently developing a treatment for COVID-19. He has joined Oxford-based biopharmaceutical company Izana Bioscience in a temporary position, after almost five years at MoFo.